Rule 8 - Powderject Pharm plc

Date : 11/25/2002 @ 6:49AM
Source : UK Regulatory (RNS and others)
Click here for ADVFN's up to the minute news service. Access our extensive collection of financial news from around the world including US, Europe and Asia.
<< Back

 



Rule 8 - Powderject Pharm plc

RNS Number:2180E
M&G Investment Management Ltd
25 November 2002

                                                                    FORM 8.1/8.3

  Lodge with Company Announcements Office and the Panel. Use a separate form for
                      each class of securities in which dealings have been made.

Date of Disclosure
25/11/2002

DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS
AND MERGERS

Date of dealing
22/11/2002

Dealing in (name of company)
Powderject Pharmaceuticals plc

1. Class of securities (eg ordinary shares)
Ordinary Shares

2.
Amount bought                  Amount sold                        Price per unit
45,000                                                            4.0600
                               40,000                             4.0200



*There has also been a transfer of -71489 shares.*

3. Resultant total of the same class owned or controlled (and percentage of
class)
9,806 ,253                                            10.76%

4. Party making disclosure
M&G Investment Management Ltd



5. EITHER (a) Name of purchaser / vendor (Note 1)
Prudential plc

OR (b) if dealing for discretionary client(s), name of fund management
organisation




6. Reason for disclosure (Note 2)




(a) associate of

(i) offeror (Note 3)

NO

(ii) offeree company

YES

Specify which category or categories of associate (1-8 overleaf)


If category (8), explain




(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the
class of relevant securities dealt in)

YES

Signed, for and on behalf of the party named in (4) above
Richard Harding

(Also print name of signatory)
Richard Harding

Telephone and Extension number
020 7548 3183

Note 1.

Specify owner, not nominee or vehicle company. If relevant, also identify
controller of owner, eg where an owner normally acts on instructions of a
controller

Note 2.

Disclosure might be made for more than one reason; if so, state all reasons.

Note 3.

Specify which offeror if there is more than one.

Note 4.

When an arrangement exists with any offeror, with the offeree company or with an
associate of any offeror or of the offeree company in relation to relevant
securities, details of such arrangement must be disclosed, as required by Note 6
on Rule 8.

Note 5.

It may be necessary, particularly when disclosing derivative transactions, to
append a sheet to this disclosure form so that all relevant information can be
given.

Note 6.

In the case of an average price bargain, each underlying trade should be
disclosed.

For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:
020 7638 0129.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCKGMZMGKLGZZM
<< Back


Powderject Pharm Historical Chart Powderject Pharm Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
40 site:2us 091125 17:32 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )